Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2013
08/08/2013WO2013113496A1 Hydroxyalkyl starch in combination with cytostatica for the treatment of cancers by reduction of tumor growth rates
08/08/2013WO2013113102A1 USE OF PDGFR-α AS DIAGNOSTIC MARKER FOR PAPILLARY THYROID CANCER
08/08/2013WO2013113097A1 Cyclic molecules as bruton's tyrosine kinase inhibitors
08/08/2013WO2013113074A1 Combination therapy comprising a growth hormone variant and an oligonucleotide targeted to the growth hormone receptor
08/08/2013WO2013113067A1 Improvements in tear film stability
08/08/2013WO2013093931A3 Novel prodrugs of phenolic drugs
08/08/2013WO2013087665A3 Composition comprising a carboxylated fructan for epidermis hydratation
08/08/2013WO2013085338A3 Pharmaceutical composition for preventing and treating metabolic diseases, comprising nymphaea tetragona root extract, fractions thereof, or polyphenol-based compounds isolated from the nymphaea tetragona root extract as active ingredients
08/08/2013WO2013083975A3 Novel pyrrole derivatives
08/08/2013WO2013083887A8 Novel association between 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide and an nmda receptor antagonist and the pharmaceutical compositions which contain said association
08/08/2013WO2013074974A3 Modified rnai agents
08/08/2013WO2013073998A3 Novel derivatives of hemin with antibacterial and antiviral activity
08/08/2013WO2013066944A3 Biomarkers for cancer characterization and treatment
08/08/2013WO2013026989A3 Liposome comprising at least one cholesterol derivative
08/08/2013WO2013021129A3 Use of a cb1 receptor antagonist as a whitening and/or anti-browning agent for keratin material
08/08/2013WO2013021128A3 Use of cannabinoid compounds for stimulating melanogenesis
08/08/2013WO2012176061A8 Trpv1 antagonists including dihydroxy substituent and uses thereof
08/08/2013WO2012015810A3 Pharmaceutical compositions containing pemetrexed having extended storage stability
08/08/2013WO2012009663A3 New compounds for treating cancer and other diseases
08/08/2013US20130204000 Crystal form of quinoline compound and process for its production
08/08/2013US20130203979 Use of lipid conjugates in the treatment of diseases
08/08/2013US20130203977 Oligonucleotides comprising alternating segments and uses thereof
08/08/2013US20130203975 Glycoside derivatives and uses thereof
08/08/2013US20130203961 Molecular Vaccine Linking an Endoplasmic Reticulum Chaperone Polypeptide to an Antigen
08/08/2013US20130203859 Methods of treating acne
08/08/2013US20130203858 Fast-Dissolving Solid Pharmaceutical Form for Treating Bacterial Infections
08/08/2013US20130203856 Filler composition for tissue reinforcement
08/08/2013US20130203854 Enhanced bimatoprost ophthalmic solution
08/08/2013US20130203853 Methods of intravenous administration of glyburide and other drugs
08/08/2013US20130203851 Use of 2,5-Dihydroxybenzenesulfonic Acid in the Manufacturing of Medicines, Applicable to the Treatment of Angiodependent Diseases
08/08/2013US20130203850 Method for treating scars with adapalene 0.3%
08/08/2013US20130203848 Compounds useful for increasing neurogenesis in neural tissue
08/08/2013US20130203844 Method for Stimulating the Reproductive Capacity in a Bull, and Composition for Stimulating the Reproductive Capacity in a Bull
08/08/2013US20130203838 Methods and compositions for inhibition of axonal degeneration by modulation of the dlk/jnk pathway
08/08/2013US20130203834 Ketorolac tromethamine compositions for treating or preventing ocular pain
08/08/2013US20130203833 Ketorolac tromethamine compositions for treating or preventing ocular pain
08/08/2013US20130203831 Non peptidic 14-3-3 inhibitors and the use thereof
08/08/2013US20130203820 Thiazolidinedione analogues
08/08/2013US20130203813 Medical devices having homogeneous charge density and methods for making same
08/08/2013US20130203811 Thalidomide and thalidomide analogues for the prevention and treatment of sarcopenia
08/08/2013US20130203809 Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
08/08/2013US20130203808 Drug for degradation and treatment of biofilms
08/08/2013US20130203807 Use of laquinimod for treating crohn's disease patients who failed first-line anti-tnf therapy
08/08/2013US20130203805 Methods for treating anemia using inhibitors of hypoxia-inducible factor (HIF) hydroxylase
08/08/2013US20130203801 Treatment of addiction
08/08/2013US20130203799 Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis
08/08/2013US20130203795 Methods for treating irritable bowel syndrome (ibs)
08/08/2013US20130203793 Protection and Treatment Against Influenza Infection
08/08/2013US20130203790 Sulfur-containing compounds as anti-proliferative agents
08/08/2013US20130203786 Substituted seven-membered heterocyclic compounds as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
08/08/2013US20130203784 Valaciclovir and diclofenac combination therapy for functional somatic syndromes
08/08/2013US20130203783 Valaciclovir and celecoxib combination therapy for functional somatic syndromes
08/08/2013US20130203782 Aciclovir and diclofenac combination therapy for functional somatic syndromes
08/08/2013US20130203781 Aciclovir and celecoxib combination therapy for functional somatic syndromes
08/08/2013US20130203780 Famciclovir and diclofenac combination therapy for functional somatic syndromes
08/08/2013US20130203779 Thioacetate compounds, compositions and methods of use
08/08/2013US20130203774 Novel compounds, use and preparation thereof
08/08/2013US20130203773 Pharmaceutical dosage form for immediate release of an indolinone derivative
08/08/2013US20130203771 Trazodone and trazodone hydrochloride in purified form
08/08/2013US20130203770 Carbamoyl derivatives of bicyclic carbonylamino-pyrazoles as prodrugs
08/08/2013US20130203769 Targeting Metabolic Adaptive Responses to Chemotherapy
08/08/2013US20130203768 N-heteroaryl compounds with cyclic bridging unit for the treatment of parasitic diseases
08/08/2013US20130203767 Treatment of Pulmonary Hypertension
08/08/2013US20130203766 Pharmaceutical Compositions for the Treatment of Sexual Disorders II
08/08/2013US20130203762 Veterinary antiprolactinic composition for ruminants
08/08/2013US20130203761 Polymorphs of Brimonidine Pamoate
08/08/2013US20130203759 ATAZANAVIR SULFATE FORMULATIONS WITH IMPROVED pH EFFECT
08/08/2013US20130203757 Compounds And Compositions For Treating Cancer
08/08/2013US20130203755 Bicyclic heteroaryl kinase inhibitors and methods of use
08/08/2013US20130203751 Substituted 8-alkoxy-2-aminotetralin derivatives, and use thereof
08/08/2013US20130203747 Inhibitors of human immunodeficiency virus replication
08/08/2013US20130203744 Aciclovir and meloxicam combination therapy for functional somatic syndromes
08/08/2013US20130203743 Famciclovir and meloxicam combination therapy for functional somatic syndromes
08/08/2013US20130203742 Valaciclovir and meloxicam combination therapy for functional somatic syndromes
08/08/2013US20130203741 Fused aminodihydrothiazine derivatives
08/08/2013US20130203739 Cyclic amide derivative
08/08/2013US20130203733 Compositions and methods for modulating interaction between polypeptides
08/08/2013US20130203730 Benzothiazoles as ghrelin receptor modulators
08/08/2013US20130203726 FtsZ INHIBITORS AS POTENTIATORS OF BETA-LACTAM ANTIBIOTICS AGAINST METHICILLIN-RESISTANT STAPHYLOCOCCUS
08/08/2013US20130203725 Method to treat small cell lung cancer
08/08/2013US20130203724 Analogs of Benzoquinone-Containing Ansamycins and Methods of Use Thereof
08/08/2013US20130203722 Estriol therapy for autoimmune and neurodegenerative disease and disorders
08/08/2013US20130203721 Taste-masked powder for suspension compositions of methylprednisolone
08/08/2013US20130203720 Testosterone gel and method of use
08/08/2013US20130203719 Use of spironolactone-based composition that exhibits an inhibitory action on t-lymphocyte activation which is usefule for preventing and/or treating multiple sclerosis
08/08/2013US20130203716 Inhaled Combination Therapy
08/08/2013US20130203715 Use of trp channel agonists to treat infections
08/08/2013US20130203714 Chemical compounds - 643
08/08/2013US20130203711 Novel herbal oil for controlling blood sugar without risk of hypoglycemea
08/08/2013US20130203710 Antiviral compound and cox-2 inhibitor combination therapy for functional somatic syndromes, including combination of famciclovir and celecoxib
08/08/2013US20130203705 Pyrazole Compounds Acting Against Allergic, Immune and Inflammatory Conditions
08/08/2013US20130203701 Compositions containing omega-3 oil and uses thereof
08/08/2013US20130203700 Cyclodextrin-based polymers for therapeutics delivery
08/08/2013US20130203698 Aqueous iron carbohydrate complexes, their production and medicaments containing them
08/08/2013US20130203697 Crosslinked hyaluronic acid composition and self-crosslinking hyaluronic acid particles
08/08/2013US20130203695 Hypersulfated disaccharides to treat elastase related disorders
08/08/2013US20130203692 Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof
08/08/2013US20130203690 Pde iii inhibitors for treatment of asymptomatic heart failure
08/08/2013US20130203688 Sugar plant derived by-products and methods of production thereof
08/08/2013US20130203680 Folate conjugates for treating inflammation of the eye
1 ... 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 ... 7860